Perfect Heal Corporation, a pharmaceutical company, changed the estimated useful life of its equipment, which is a substantial part of its assets, from $10$ years to $5$ years in $2013.$ The change in the estimated life of the asset is allowed under the reporting standards of the company's jurisdiction. The change was made in anticipation of a substantial increase in the tax rates within the next $5$ years. The financial footnotes disclose the change in the estimated useful life of the company's equipment even though with limited explanation. However, its MD&A report makes no mention of the anticipated change in the tax rate and its implications. Based solely on the given information, evaluate the financial reporting quality and the earnings quality of Perfect Heal for the year $2013.$